Arie Perry, MD

Arie Perry, MD

Professor of Pathology and Neurological Surgery; Director of Neuropathology; Director of Neuropathology Fellowship Training Program
Specialty Areas
Surgical Neuropathology
Brain Tumors - Pediatric and Adult

Pathology, Box 0102
505 Parnassus Avenue, Room M-553
San Francisco, CA 94143
United States

Hospital Affiliations
UCSF Parnassus Heights
Research and Clinical Interests

My clinical interests focus most heavily on surgical neuropathology and molecular neuropathology, especially in terms of their applications in neuro-oncology. As a diagnostic neuropathologist with a focus on CNS tumors, I am primarily involved in translational research with the primary goal of developing new diagnostic and prognostic markers, which can be utilized in the clinical management of brain tumor patients. In order to achieve this goal, my research has applied immunohistochemical, molecular cytogenetic, and genomic screening techniques primarily towards the study of gliomas, meningiomas, nerve sheath tumors, and primitive pediatric malignancies. I have been particularly interested in improved classification and grading schemes as well as the identification of molecular genetic markers associated with tumorigenesis, malignant progression, and/or biologic behavior. I collaborate with a number of clinical and scientific researchers both within and outside UCSF and it is our hope that the biomarkers we identify will improve patient management and lead to the development of novel therapeutic approaches. I also maintain a private consultation service for difficult surgical neuropathology cases obtained from the U.S. and abroad, particularly brain tumors.

Selected Publications
  • Asa SL, Perry A. Tumors of the Pituitary Gland. AFIP Atlas of Tumor and Non-tumor Pathology, 5th series Fascicle 1, ARP Press, Arlington, VA, 2020.
  • Perry A, Brat DJ (ed.) Practical Surgical Neuropathology, 2nd Edition. Elsevier/Churchill Livingstone, Philadelphia, PA 2018.
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (ed.): WHO classification of tumours of the central nervous system (Revised 4th edition). IARC: Lyon 2016.
  • Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters B, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M. cIMPACT-NOW Update 3: Grading of IDH-wildtype diffuse astrocytic gliomas. Acta Neuropathol 136:805-10, 2018.
  • Miettinen MM, Antonescu CR, Fletcher CD, Kim A, Lazar AJ, Quezado MM, Reilly KM, Stemmer-Rachamamimov A, Stewart D, Viskochil D, Widemann B, Perry A. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in neurofibromatosis 1 patients – A consensus overview. Hum Pathol 67:1-10, 2017.
  • 2018-2021: Elected as a Board of Directors Member for the United States and Canadian Academy of Pathology (USCAP)
  • 2017-Now: Member of International Collaboration on Cancer Reporting (ICCR) for the development of a reporting protocol for tumours of the central nervous system (CNS).
  • 2016-Now: Member of cIMPACT NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.
  • 2016-Now: Appointed to the Editorial Advisory Board (EAB) for the American Registry of Pathology (ARP) Publications / Armed Forces Institute of Pathology (AFIP) Fascicles.
  • 2016-2017: President of the American Association of Neuropathologists (AANP).
  • 2015-2018: Vice President of International Society of Neuropathology (ISN).
  • 2014: Appointed as Senior Reviewer/Editor for World Health Organization (WHO) 4th edition brain tumor classification scheme update.
  • 2013: Nominated for MS1 Essential Core Teaching Award, UCSF (Medical School Class of 2016).
  • 2008: Professor of the Year Award, Washington University School of Medicine (Medical School Class of 2010).
Additional Information

Educational Links: